Showing 5021-5030 of 5771 results for "".
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent-2/2476882/Bio-Tissue, a TissueTech company, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech Vice P
- Zeiss to Showcase Advancements in Digital and Surgical Technology at ESCRShttps://modernod.com/news/zeiss-to-showcase-advancements-in-digital-and-surgical-technology-at-escrs/2476881/During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) annual meeting in Paris, Zeiss will p
- Cassini to Reveal New Cassini Device at ESCRShttps://modernod.com/news/cassini-to-reveal-new-cassini-device-at-the-escrs-in-paris/2476880/Cassini announced that it will reveal its new Cassini device at the 37th Congress of European Society of Cataract and Refractive Surgeons in Paris. This product introduction marks the next chapter of product design, with latest camera technology, improved patient comfort and great usability.
- PhysIOL to Launch FineVision Triumf Trifocal EDOF IOLhttps://modernod.com/news/physiol-to-launch-finevision-triumf-trifocal-edof-iol/2476879/BVI, through its PhysIOL subsidiary, announced the European launch of the FineVision Triumf EDOF trifocal presbyopia correcting IOL. Results from a year of clinical studies will be presented at the European Society for Cataract and Refractive Surgeons (ESCRS), held Septembe
- SightGlass Vision to Present Pivotal Clinical Trial Baseline Data Evaluating Novel Lenses to Control Nearsightedness in Childrenhttps://modernod.com/news/sightglass-vision-to-present-pivotal-clinical-trial-baseline-data-evaluating-novel-lenses-to-control-nearsightedness-in-children/2476876/SightGlass Vision announced that baseline data from CYPRESS, the company’s pivotal trial assessing the safety and efficacy of novel lenses designed to control nearsightedness in children, will be presented at the 17th International Myopia Conference 2019, held
- Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for Wet AMDhttps://modernod.com/news/kodiak-sciences-to-release-durability-data-from-clinical-development-program-of-ksi-301-for-wet-amd/2476877/Kodiak Sciences announced that updated data from the clinical development program for its investigational therapy KSI-301 will be presented at The Retina Society Annual Meeting on September 15 in London. “Developing intra
- Boost Epi-On Corneal Cross-Linking Data to Be Presented at ESCRShttps://modernod.com/news/boost-epi-on-corneal-cross-linking-data-to-be-presented-at-escrs/2476874/Avedro announced the inclusion of a wide array of Boost Epi-On cross-linking (CXL) presentations in the scientific and educational programs at the 10th EU Cornea Congress and the 37th Congress of the European Society
- Johnson & Johnson Vision to Launch Tecnis Synergy IOL and Showcase Latest Clinical Data at ESCRShttps://modernod.com/news/johnson-johnson-vision-showcases-latest-clinical-data-and-eye-care-solutions-at-escrs-2/2476873/Johnson & Johnson Vision will highlight key clinical data and the latest solutions in its growing portfolio of innovative products designed to improve vision care across generations at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) 2019 Annual Meeting in Paris, Fran
- MicroPulse Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRShttps://modernod.com/news/micropulse-transscleral-laser-therapy-will-be-discussed-in-various-presentations-and-educational-events-at-escrs/2476872/Iridex announced that its patented MicroPulse laser therapy will be featured prominently in research presented at the 2019 European Society of Cataract & Refractive Surgeons (ESCRS) meeting, to be held in Paris, France. MicroPulse Transscleral Laser Therapy (TLT) is a non-incisional, laser-ba
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent/2479535/Bio-Tissue, a subsidiary of TissueTech, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech